Microenvironment-dependent resistance to ABT-737 in chronic lymphocytic leukemia Response

被引:1
|
作者
Butterworth, Michael [1 ]
Vogler, Meike [1 ]
Dyer, Martin J. S. [1 ]
Cohen, Gerald M. [1 ]
机构
[1] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England
关键词
PROLIFERATION; INHIBITORS; APOPTOSIS; LYMPHOMA; BALANCE; CXCR4; CELLS;
D O I
10.1182/blood-2009-07-232926
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2561 / 2562
页数:4
相关论文
共 50 条
  • [1] Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
    Tromp, Jacqueline M.
    Geest, Christian R.
    Breij, Esther C. W.
    Elias, Judith A.
    van Laar, Jacoline
    Luijks, Dieuwertje M.
    Kater, Arnon P.
    Beaumont, Tim
    van Oers, Marinus H. J.
    Eldering, Eric
    CLINICAL CANCER RESEARCH, 2012, 18 (02) : 487 - 498
  • [2] An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737
    Al-Harbi, Sayer
    Hill, Brian T.
    Mazumder, Suparna
    Singh, Kamini
    DeVecchio, Jennifer
    Choudhary, Gaurav
    Rybicki, Lisa A.
    Kalaycio, Matt
    Maciejewski, Jaroslaw P.
    Houghton, Janet A.
    Almasan, Alexandru
    BLOOD, 2011, 118 (13) : 3579 - 3590
  • [3] Diminished Sensitivity of Chronic Lymphocytic Leukemia Cells to ABT-737 and ABT-263 Due to Albumin Binding in Blood
    Vogler, Meike
    Furdas, Silviya D.
    Jung, Manfred
    Kuwana, Tomomi
    Dyer, Martin J. S.
    Cohen, Gerald M.
    CLINICAL CANCER RESEARCH, 2010, 16 (16) : 4217 - 4225
  • [4] Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737
    Bates, Darcy J. P.
    Danilov, Alexey V.
    Lowrey, Christopher H.
    Eastman, Alan
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) : 1504 - 1514
  • [5] Synergistic Response Induced by Quercetin and ABT-737 in Leukemic Cell Lines and in B-Cells Isolated From Chronic Lymphocytic Leukemia
    Russo, G. L.
    Spagnuolo, C.
    Russo, M.
    Volpe, S.
    Tedesco, I.
    Bilotto, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S200 - S200
  • [6] Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo
    Soderquist, R.
    Bates, D. J. P.
    Danilov, A. V.
    Eastman, A.
    LEUKEMIA, 2013, 27 (11) : 2262 - 2264
  • [7] Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo
    R Soderquist
    D J P Bates
    A V Danilov
    A Eastman
    Leukemia, 2013, 27 : 2262 - 2264
  • [8] The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
    Mason, K. D.
    Khaw, S. L.
    Rayeroux, K. C.
    Chew, E.
    Lee, E. F.
    Fairlie, W. D.
    Grigg, A. P.
    Seymour, J. F.
    Szer, J.
    Huang, D. C. S.
    Roberts, A. W.
    LEUKEMIA, 2009, 23 (11) : 2034 - 2041
  • [9] The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
    K D Mason
    S L Khaw
    K C Rayeroux
    E Chew
    E F Lee
    W D Fairlie
    A P Grigg
    J F Seymour
    J Szer
    D C S Huang
    A W Roberts
    Leukemia, 2009, 23 : 2034 - 2041
  • [10] Enhancement of the Sensitivity of the Acute Lymphoblastic Leukemia Cells to ABT-737 by Formononetin
    Abbasi, Yusef
    Pooladi, Marziyeh
    Nazmabadi, Roya
    Amri, Jamal
    Abbasi, Helia
    Aghabeygi, Razieh
    Karami, Hadi
    INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2024, 13 (03) : 259 - 271